Shanghai Pharmaceuticals Holding Co., Ltd. (02607) has issued a proxy form for an Extraordinary General Meeting scheduled on 9 December 2025 at 14:00. The meeting will take place at Meeting Room, 2nd Floor, Shanghai Pharma Building, No. 200 Taicang Road, Huangpu District, Shanghai.

The agenda includes one special resolution involving the abolishment of the supervisory board and corresponding amendments to the Articles of Association and its appendices. There are also three ordinary resolutions, covering proposed amendments to the Implementation Rules of the Cumulative Voting System and to the Administrative Measures for Raised Funds, as well as a 2025 Interim Profit Distribution Plan.

Shareholders must submit the completed proxy form and relevant documents to the designated H Share registrar at least 24 hours prior to the meeting. Attendance and voting can be in person or by proxy. If no voting instructions are specified on the proxy form, the appointed proxy will vote at their discretion. Shareholders who deliver the required documentation on time retain the option to attend the meeting and vote in person.